Phase 3
N=85
Effect of Vitamin D on Metabolic Profile in Overweight or Obese Women
Overweight · Obesity
Bottom Line
View on ClinicalTrials.gov: NCT01344161 ↗Enrolled (actual)
85
Serious AEs
0.0%
Results posted
Jul 2012
Primary outcome: Primary: Change in Body Fat Mass — -2.7; -0.4 kg — p=0.001
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Placebo (Dietary_supplement); vitamin D (Dietary_supplement)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Tehran University of Medical Sciences
- Primary completion
- Feb 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Body Fat Mass |
-2.7; -0.4 | 0.001 sig |
| PRIMARY Change in Glucose Concentrations |
-0.28; -0.65 | — |
| PRIMARY Change in Post Load Glucose Concentrations |
-0.29; -0.3 | — |
| PRIMARY Change in Insulin Concentrations |
-24.8; -19 | — |
Summary
The investigators investigated the effect of vitamin D3 supplementation on metabolic profile (anthropometric measures, blood pressure Lipids, lipoproteins and glycemic indices) in overweight or obese women.
Eligibility Criteria
Inclusion Criteria
- Female
- 18-50 years old
- Premenopause
- BMI ≥25
Exclusion Criteria
- Cardiovascular disease
- Liver disease
- Gastrointestinal disease
- Kidney disease
- Diabetes mellitus
- Osteoporosis
- Pregnancy
- Lactation
Data sourced from ClinicalTrials.gov (NCT01344161). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.